ReviewHuman vaccines & immunotherapeutics2024

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data.

Frank van den Ouweland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.